pre-ipo
Stage
About
Vaxcyte is a clinical-stage biotechnology company developing vaccines to prevent serious bacterial infections including invasive pneumococcal disease, Group A Streptococcus, and Shigella using advanced synthetic and cell-free protein synthesis technologies.
Explore Vaxcyte's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.